Esther Hong
Stock Analyst at Loop Capital
(n/a)
# 4,719
Out of 5,113 analysts
15
Total ratings
9.09%
Success rate
-38.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Hong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATAI AtaiBeckley | Initiates: Buy | $18 | $4.15 | +333.73% | 2 | Nov 1, 2022 | |
| ACAD ACADIA Pharmaceuticals | Initiates: Hold | $17 | $26.84 | -36.66% | 2 | Nov 1, 2022 | |
| CMPS COMPASS Pathways | Initiates: Buy | $34 | $7.17 | +374.20% | 1 | Nov 1, 2022 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $95 | $185.96 | -48.91% | 2 | Nov 1, 2022 | |
| SPRO Spero Therapeutics | Downgrades: Hold | $2 | $2.44 | -18.03% | 2 | May 20, 2022 | |
| APRE Aprea Therapeutics | Downgrades: Hold | n/a | $0.83 | - | 2 | Aug 16, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | $32 | $5.19 | +516.57% | 4 | Dec 16, 2020 |
AtaiBeckley
Nov 1, 2022
Initiates: Buy
Price Target: $18
Current: $4.15
Upside: +333.73%
ACADIA Pharmaceuticals
Nov 1, 2022
Initiates: Hold
Price Target: $17
Current: $26.84
Upside: -36.66%
COMPASS Pathways
Nov 1, 2022
Initiates: Buy
Price Target: $34
Current: $7.17
Upside: +374.20%
Axsome Therapeutics
Nov 1, 2022
Initiates: Buy
Price Target: $95
Current: $185.96
Upside: -48.91%
Spero Therapeutics
May 20, 2022
Downgrades: Hold
Price Target: $2
Current: $2.44
Upside: -18.03%
Aprea Therapeutics
Aug 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $0.83
Upside: -
Aldeyra Therapeutics
Dec 16, 2020
Initiates: Buy
Price Target: $32
Current: $5.19
Upside: +516.57%